Pros and cons of Dong-A ST’s Baraclude generic early launch

Despite existence of the substance patent, Dong-A ST launched a Baraclude generic on the 7^th, giving various explanations in the industry. The explanations are divided into two opinions, 'risk' and ‘worth to try.’

In order to take advantages of early launching, Dong-A ST must minimize compensation for patent infringement damages and preoccupy the market in a month.

First, there is a high chan...